What is SIBN's market cap?

$1.12B, based on the Nov 4 close of $24.95.

Does SI-BONE pay a dividend?

No regular cash dividend has been paid in the last year.

How much of SIBN is sold short?

4.7M shares, 10.9% of float, as of Oct 15, 2026.

What sector is SIBN in?

Healthcare, in the Surgical Instruments industry.

NASDAQ · SIBNHealthcareSurgical Instruments

SI-BONE, Inc. Common Stock (SIBN)

$24.95+4.96%

Close Nov 4, 2026 · split-adjusted

Nov 4, 2026$25.36▲ 68.54% in range

Nov 3, 2025Low $11.61 · High $25.36Nov 4, 2026

What changed · written from our data

As of Nov 4, 2026

SI-BONE closed at $24.95 on Nov 4, up 4.96% — matching its 52-week closing high. Volume of 2.2M shares was 2.76× its 20-day average (well above normal).

Split-adjusted performance: +27.6% over one month, +92.1% over six months, +65.8% over one year.

In the quarter ended Jun 30, 2026, revenue was $56.01M, up 15.2% from a year earlier, with a net margin of -7.3%.

Short interest was 4.7M shares at the Oct 15 settlement, down 8.0% from the prior report (10.9% of float, 8.7 days to cover).

Market cap$1.12B44.8M shares

Revenue · quarter$56.0M+15.2% YoY

Diluted EPS$-0.09—

P/E · TTM—P/S 5.2×

Net margin-7.3%Gross 79.5%

Dividend yieldNone

52-week range11.61 – 24.950.0% from high

Volume2.2M2.76× 20-day avg

Volatility · 60d49.6%Annualised

Short % of float10.9%8.7 days to cover

Net cash$110.3MCash $145.9M

Next earnings—Not scheduled

Split-adjusted performance

1W +14.3%1M +27.6%3M +37.5%6M +92.1%YTD +26.5%1Y +65.8%3Y +51.2%5Y +12.8%

Earnings reactions

History →

No reported quarters with price history yet.

Rank within Surgical Instruments

Percentile among 110 companies (100 = best)

6-month momentum92

Revenue growth62

Net margin52

Value (low P/E)—

Size68

Industry medians: 6-month return −4.0%, revenue growth +8.9%, net margin −8.2%, P/E 30.5×.

Short interest

Details →

Shares short4.7M−8.0% vs prior

Days to cover8.7Settled Oct 15

% of float10.9%

Short vol. 10d36.1%of daily volume

Closest peers by size in Surgical Instruments

Company	Price	Today	6M	Rev. growth	Net margin	P/E	Mkt cap
SIBNSI-BONE	$24.95	+4.96%	+92.1%	+15.2%	−7.3%	—	$1.12B
IRMDiRadimed	$88.58	+9.21%	+2.7%	+14.2%	26.9%	47.2	$1.13B	Compare
SGPSpyGlass Pharma	$34.45	0.00%	+37.5%	—	—	—	$1.15B	Compare
IARTIntegra LifeSciences	$14.82	+8.73%	+5.9%	+2.3%	3.6%	88.6	$1.15B	Compare
PRCTPROCEPT BioRobotics	$21.66	+7.39%	−12.7%	+19.3%	−28.4%	—	$1.24B	Compare
ATECAlphatec Holdings	$8.28	+10.84%	+18.5%	+12.6%	−2.5%	—	$1.27B	Compare
AORTArtivion	$26.45	+11.56%	−23.8%	+11.3%	−10.7%	—	$1.29B	Compare
TNDMTandem Diabetes Care	$19.05	+7.93%	+5.7%	+5.8%	−8.3%	—	$1.33B	Compare
BBNXBeta Bionics	$16.95	+12.25%	+60.4%	+30.3%	−68.6%	—	$921.5M	Compare

News about SI-BONE

All news →

Si-Bone (SIBN) Reports Q3 Loss, Tops Revenue EstimatesZacks Investment Research · 2d agoNeutral Why Si-Bone Stock Soared by Almost 20% on TuesdayThe Motley Fool · May 12, 2026▲ Positive

Quick answers

What does SI-BONE do?: SI-BONE Inc is a medical device company that develops and commercializes a proprietary minimally invasive surgical implant system in the United States and internationally. Its products include a series of patented titanium implants and the instruments used to implant them, as well as implantable bone products such as iFuse-3D, iFuse-TORQ, and iFuse Bedrock Granite, which have applications across sacroiliac joint dysfunction and fusion, adult spinal deformity and degeneration, and pelvic trauma.
What is SIBN's market cap?: $1.12B, based on the Nov 4 close of $24.95.
Does SI-BONE pay a dividend?: No regular cash dividend has been paid in the last year.
How much of SIBN is sold short?: 4.7M shares, 10.9% of float, as of Oct 15, 2026.
What sector is SIBN in?: Healthcare, in the Surgical Instruments industry.

About SI-BONE

SI-BONE Inc is a medical device company that develops and commercializes a proprietary minimally invasive surgical implant system in the United States and internationally. Its products include a series of patented titanium implants and the instruments used to implant them, as well as implantable bone products such as iFuse-3D, iFuse-TORQ, and iFuse Bedrock Granite, which have applications across sacroiliac joint dysfunction and fusion, adult spinal deformity and degeneration, and pelvic trauma.

HQ: San Jose, CA376 employeesListed Oct 17, 2018si-bone.com

Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology